Get started
Work

Organ Function and Quality of Life Correlates at Randomization on the Scot (Scleroderma: Cyclophosphamide or Transplantation) Trial

Year: 2011
Type: article
Abstract: Autoimmune diseases offer unique opportunities to measure disease burden and response to immunomodulation with hematopoietic cell transplantation (HCT). To study baseline impairments in health-related quality of life (HR-QOL), we analyzed correlates of HR-QOL indices among patients with diffuse systemic sclerosis (SSc) participating in the SCOT trial.
DOI: 10.1016/j.bbmt.2010.12.134
Authors: K.M. Sullivan, D.B. Froshaug, D.E. Furst, R.A. Nash, M.D. Mayes, L.J. Crofford, P.A. McSweeney, E.A. Goldmuntz, L. Keyes-Elstein, D. Khanna
Institutions: Duke Medical Center, Rho (United States), University of California, Los Angeles, Fred Hutch Cancer Center, University of Kentucky, Rocky Mountain Cancer Centers, National Institutes of Health
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W1969185722
FWCI:
Cites:
Cited by:
Related to: 10